Evidence map›Paper›PMID 28781888›Full record

ArticleNPJ genomic medicine2017

A GWAS in uveal melanoma identifies risk polymorphisms in the

Lenha Mobuchon, Aude Battistella, Claire Bardel, Ghislaine Scelo, Alexia Renoud, Alexandre Houy, Nathalie Cassoux, Maud Milder, Géraldine Cancel-Tassin, Olivier Cussenot and 6 more

Open access · goldAbstract read
In one paragraph

Article in NPJ genomic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Germline MBD4 Mutations and Predisposition to Uveal Melanoma.Journal of the National Cancer Institute · 2021
    Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Lenha MobuchonInserm U830 and Ensemble Hospitalier, PSL Research University, Institut Curie, Paris, France.
Aude BattistellaInserm U830 and Ensemble Hospitalier, PSL Research University, Institut Curie, Paris, France.
Claire BardelUMR5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique-Santé, Université Claude Bernard-Lyon 1, Lyon, France.
Ghislaine SceloInternational Agency for Research on Cancer (IARC), Lyon, France.
Alexia RenoudINSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Alexandre HouyInserm U830 and Ensemble Hospitalier, PSL Research University, Institut Curie, Paris, France.
Nathalie CassouxInserm U830 and Ensemble Hospitalier, PSL Research University, Institut Curie, Paris, France.
Maud MilderInserm U830 and Ensemble Hospitalier, PSL Research University, Institut Curie, Paris, France.
Géraldine Cancel-TassinUPMC University Paris 06 GRC n°5, CeRePP, Hôpital Tenon, Paris, France.
Olivier CussenotUPMC University Paris 06 GRC n°5, CeRePP, Hôpital Tenon, Paris, France.
Olivier DelattreInserm U830 and Ensemble Hospitalier, PSL Research University, Institut Curie, Paris, France.
Céline BesseCentre National de Génotypage, Institut de Génomique, CEA, Evry, France.
Anne BolandCentre National de Génotypage, Institut de Génomique, CEA, Evry, France.
Jean-François DeleuzeCentre National de Génotypage, Institut de Génomique, CEA, Evry, France.
David G CoxINSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Marc-Henri SternInserm U830 and Ensemble Hospitalier, PSL Research University, Institut Curie, Paris, France.
Inserm · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRUniversité Claude Bernard Lyon 1 · FRSorbonne Université · FRCentre international de recherche sur le cancer · FR

Funding

Pooled genome-wide analysis of kidney cancer riskU01CA155309 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI SCELO, GHISLAINE · 2011 to 2014
$3.7M
NCI NIH HHS U01 CA155309World Health Organization 001
6 · The paper itself

Abstract

Uveal melanoma, a rare malignant tumor of the eye, is predominantly observed in populations of European ancestry. A genome-wide association study of 259 uveal melanoma patients compared to 401 controls all of European ancestry revealed a candidate locus at chromosome 5p15.33 (region rs421284: OR = 1.7, CI 1.43-2.05). This locus was replicated in an independent set of 276 cases and 184 controls. In addition, risk variants from this region were positively associated with higher expression of

Identifiers

PMID28781888
PMCPMC5542017
OpenAlexW2594742421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.